Simona Biosystems

Simona Biosystems is a private, pre-revenue AI/ML research company founded in 2018 and based in Copenhagen. The company is developing a proprietary technology platform that blends cutting-edge AI, specifically equivariant neural networks, with molecular dynamics to simulate and predict biological phenomena at the atomic level. Its primary work involves redefining the N-body problem as a benchmark for geometric deep learning and applying these models to complex simulations like solvation processes. The company appears to be in an early R&D stage, publishing foundational research with the goal of creating a platform that could eventually empower researchers in drug design and material science.

A proprietary platform applying geometric deep learning, specifically equivariant graph neural networks (like Ponita), to molecular dynamics simulations. It trains neural networks to predict atomic and molecular trajectories over larger time steps than traditional numerical integrators, aiming to drastically accelerate computational simulations while preserving physical accuracy.

Competes with established molecular dynamics software companies (e.g., Schrödinger) and large-scale, in-house AI simulation efforts at major pharma and tech-biotechs (e.g., Isomorphic Labs). Its differentiation is a deep, published focus on the foundations of geometric deep learning for physics simulation, rather than direct therapeutic development.